Catalog Number UNK FLUENCYPLUS VASC STNT GRFT |
Device Problems
Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Restenosis (4576)
|
Event Date 11/06/2018 |
Event Type
Injury
|
Event Description
|
It was reported through a retrospective study that the stent graft was implanted in the right common iliac artery to treat an in-stent restenosis.Approximately nine months after stent implantation, the patient developed in-stent edge restenosis.The event was assessed as being likely related to the study device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
Manufacturing review: a lot history review, a device history record review and complete manufacturing review could not be conducted for the investigation as the lot number is unknown.Investigation summary: the sample was not returned for evaluation and image was not provided.In this case, an edge in-stent restenosis, which could lead to an occlusion, was identified.Based on the information available a potential relation to the device or a potential device deficiency could not be verified.Therefore, the investigation is inconclusive for the reported issue.A definitive root cause could not be determined based upon the available information.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use sufficiently address the potential risks.Regarding the potential complications, which may occur during or after the implantation of the stent graft, the instructions for use includes: thrombosis.Occlusion and restenosis.The catalog number identified has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified.Device not returned.
|
|
Manufacturer Narrative
|
Manufacturing review: a lot history review, a device history record review and complete manufacturing review could not be conducted for the investigation as the lot number is unknown.Investigation summary: the sample was not returned for evaluation and image was not provided.In this case, an edge in-stent restenosis, which could lead to an occlusion, was identified.Based on the information available a potential relation to the device or a potential device deficiency could not be verified.Therefore, the investigation is inconclusive for the reported issue.A definitive root cause could not be determined based upon the available information.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use sufficiently address the potential risks.Regarding the potential complications, which may occur during or after the implantation of the stent graft, the instructions for use includes: thrombosis.Occlusion and restenosis.H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified in d2 and g4.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported through a retrospective study that the stent graft was implanted in the right common iliac artery to treat an in-stent restenosis.Approximately nine months after stent implantation, the patient developed in-stent edge restenosis.The event was assessed as being likely related to the study device.The current status of the patient is unknown.
|
|
Search Alerts/Recalls
|
|